| An extent of resection threshold for newly diagnosed glioblastomas N Sanai, MY Polley, MW McDermott, AT Parsa, MS Berger Journal of neurosurgery 115 (1), 3-8, 2011 | 1755 | 2011 |
| An international Ki67 reproducibility study MYC Polley, SCY Leung, LM McShane, D Gao, JC Hugh, ... Journal of the National Cancer Institute 105 (24), 1897-1906, 2013 | 702 | 2013 |
| Assessment of Ki67 in breast cancer: updated recommendations from the international Ki67 in breast cancer working group TO Nielsen, SCY Leung, DL Rimm, A Dodson, B Acs, S Badve, C Denkert, ... JNCI: Journal of the National Cancer Institute 113 (7), 808-819, 2021 | 586 | 2021 |
| Insular glioma resection: assessment of patient morbidity, survival, and tumor progression N Sanai, MY Polley, MS Berger Journal of neurosurgery 112 (1), 1-9, 2010 | 418 | 2010 |
| Dose-adjusted EPOCH-R compared with R-CHOP as frontline therapy for diffuse large B-cell lymphoma: clinical outcomes of the phase III intergroup trial alliance/CALGB 50303 NL Bartlett, WH Wilson, SH Jung, ED Hsi, MJ Maurer, LD Pederson, ... Journal of clinical oncology 37 (21), 1790-1799, 2019 | 410 | 2019 |
| Functional mapping–guided resection of low-grade gliomas in eloquent areas of the brain: improvement of long-term survival EF Chang, A Clark, JS Smith, MY Polley, SM Chang, NM Barbaro, ... Journal of neurosurgery 114 (3), 566-573, 2011 | 337 | 2011 |
| An international study to increase concordance in Ki67 scoring MYC Polley, SCY Leung, D Gao, MG Mastropasqua, LA Zabaglo, ... Modern pathology 28 (6), 778-786, 2015 | 301 | 2015 |
| Oncogenic BRAF Mutation with CDKN2A Inactivation Is Characteristic of a Subset of Pediatric Malignant Astrocytomas JD Schiffman, JG Hodgson, SR VandenBerg, P Flaherty, MYC Polley, ... Cancer research 70 (2), 512-519, 2010 | 296 | 2010 |
| Criteria for the use of omics-based predictors in clinical trials LM McShane, MM Cavenagh, TG Lively, DA Eberhard, WL Bigbee, ... Nature 502 (7471), 317-320, 2013 | 270 | 2013 |
| Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide G Prasad, T Sottero, X Yang, S Mueller, CD James, WA Weiss, MY Polley, ... Neuro-oncology 13 (4), 384-392, 2011 | 195 | 2011 |
| Statistical and practical considerations for clinical evaluation of predictive biomarkers MYC Polley, B Freidlin, EL Korn, BA Conley, JS Abrams, LM McShane Journal of the National Cancer Institute 105 (22), 1677-1683, 2013 | 156 | 2013 |
| Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration LM McShane, MM Cavenagh, TG Lively, DA Eberhard, WL Bigbee, ... BMC medicine 11, 1-22, 2013 | 139 | 2013 |
| En bloc resection for primary and metastatic tumors of the spine: a systematic review of the literature JM Cloyd, FL Acosta Jr, MY Polley, CP Ames Neurosurgery 67 (2), 435-445, 2010 | 128 | 2010 |
| Heparan sulfate sulfatase SULF2 regulates PDGFRα signaling and growth in human and mouse malignant glioma JJ Phillips, E Huillard, AE Robinson, A Ward, DH Lum, MY Polley, ... The Journal of clinical investigation 122 (3), 911-922, 2012 | 115 | 2012 |
| Impact of bevacizumab chemotherapy on craniotomy wound healing AJ Clark, NA Butowski, SM Chang, MD Prados, J Clarke, MYC Polley, ... Journal of neurosurgery 114 (6), 1609-1616, 2011 | 111 | 2011 |
| Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer RA Leon-Ferre, MY Polley, H Liu, JA Gilbert, V Cafourek, DW Hillman, ... Breast cancer research and treatment 167, 89-99, 2018 | 109 | 2018 |
| CALGB 40603 (Alliance): long-term outcomes and genomic correlates of response and survival after neoadjuvant chemotherapy with or without carboplatin and bevacizumab in triple … JH Shepherd, K Ballman, MYC Polley, JD Campbell, C Fan, S Selitsky, ... Journal of Clinical Oncology 40 (12), 1323-1334, 2022 | 101 | 2022 |
| Survival, pathologic response, and genomics in CALGB 40601 (Alliance), a neoadjuvant phase III trial of paclitaxel-trastuzumab with or without lapatinib in HER2-positive breast … A Fernandez-Martinez, IE Krop, DW Hillman, MY Polley, JS Parker, ... Journal of Clinical Oncology 38 (35), 4184-4193, 2020 | 101 | 2020 |
| Quality of life in low-grade glioma patients receiving temozolomide R Liu, K Solheim, MY Polley, KR Lamborn, M Page, A Fedoroff, J Rabbitt, ... Neuro-oncology 11 (1), 59-68, 2009 | 99 | 2009 |
| Randomized phase II trial designs with biomarkers B Freidlin, LM McShane, MYC Polley, EL Korn Journal of Clinical Oncology 30 (26), 3304-3309, 2012 | 97 | 2012 |
